학술논문

Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses
Document Type
Article
Source
In: Immunity. (Immunity, 8 March 2022, 55(3):512-526.e9)
Subject
Language
English
ISSN
10974180
10747613